Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$16.7K Sell
200
-150
-43% -$12K ﹤0.01% 539
2023
Q4
$27.3K Buy
350
+150
+75% +$11.1K ﹤0.01% 482
2023
Q3
$15.4K Hold
200
﹤0.01% 528
2023
Q2
$16.4K Sell
200
-137
-41% -$10.5K ﹤0.01% 547
2023
Q1
$23.8K Hold
337
﹤0.01% 527
2022
Q4
$23K Buy
337
+200
+146% +$12.8K ﹤0.01% 538
2022
Q3
$8K Sell
137
-43
-24% -$2.98K ﹤0.01% 669
2022
Q2
$13K Buy
180
+157
+683% +$11.5K ﹤0.01% 650
2022
Q1
$2K Sell
23
-340
-94% -$26.3K ﹤0.01% 866
2021
Q4
$32K Buy
+363
New +$29.9K ﹤0.01% 603
2019
Q3
Sell
-5,747
Closed -$357K 258
2019
Q2
$357K Buy
+5,747
New +$337K 0.02% 194

Other funds holding ALC

Cambridge Trust's ALC Position: Q1 2024 in Review

Cambridge Trust reduced its Alcon (ALC) stake by 43% in Q1 2024, selling an estimated $12K and leaving 200 shares worth $16.7K. The position accounts for ﹤0.01% of the portfolio, ranked #539.

Cambridge Trust first reported a position in ALC in Q2 2019 and has held it in 11 quarters since. The position peaked at $357K in Q2 2019. 617 funds tracked by Wall St. Rank hold ALC as of Q1 2024.

  • Cambridge Trust held 200 shares of Alcon worth $16.7K as of Q1 2024.
  • Cambridge Trust sold 150 Alcon shares in Q1 2024, an estimated $12K.
  • Alcon made up ﹤0.01% of Cambridge Trust's portfolio in Q1 2024, its #539 holding.
  • Cambridge Trust first reported a position in Alcon in Q2 2019 and has held it in 11 quarters since.
  • Cambridge Trust's Alcon position peaked at $357K in Q2 2019.
  • 617 funds tracked by Wall St. Rank held Alcon as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.